Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Drug Alcohol Depend. 2013 Oct 12;134:222–227. doi: 10.1016/j.drugalcdep.2013.10.001

Table 5.

The Relation of Marijuana Use during HCV Treatment to Treatment Failure, Adjusted for Host and Viral Risk Factors. Multiple Logistic Regression, Adjusted Odds Ratios, 95% Confidence Intervals (CI). (N = 173)

Risk Factors Odds Ratios (95% CI) ρ Values
Hispanic and/or non-White 2.30 (.998 – 5.29) .051
Pretreatment Viral Load 2.19 (1.11 – 4.33) .024
HCV Genotype 1/4/6 4.32 (2.15 – 8.70) <.001
Advanced Fibrosis 1.86 (.933 – 3.71) .078
Treatment Discontinuation 7.85 (2.66 – 23.2) <.001
Marijuana Use During Treatment 3.45 (1.04– 11.5) .043